Lebwohl, M. G., Mehta, N. N., Gottlieb, A. B., & Mendelsohn, A. M. (2020). Tildrakizumab Efficacy by Metabolic Syndrome Status in Psoriasis: Post Hoc Analysis of 3-Year Data from the Phase 3 Resurface 1 And Resurface 2 Studies. SKIN The Journal of Cutaneous Medicine, 4(5), s42. https://doi.org/10.25251/skin.4.supp.42